Medifast, Inc. · Owings Mills, MD United States (NYSE: MED)
Key Medifast, Inc. Financials
| Company Type | Public -(NYSE: MED) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2010 Sales (mil.) | $257.6 |
| 2010 Employees | 507 |
Medifast, Inc. Stock Quote (NYSE: MED)
| Latest 02/15/12 11:27:00 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $17.72 | $17.72 | $17.41 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Medifast, Inc. Income Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Revenue | 257.6 | 165.6 | 105.4 |
| Cost of Goods Sold | 65.1 | 40.3 | 25.3 |
| Gross Profit | 192.5 | 125.3 | 80.1 |
| Gross Profit Margin | 74.7% | 75.7% | 76% |
| SG&A Expense | 160.8 | 106.0 | 71.9 |
| Depreciation & Amortization | 5.9 | 5.3 | 4.6 |
| Operating Income | 31.6 | 19.4 | 8.2 |
| Operating Margin | 12.3% | 11.7% | 7.8% |
| Nonoperating Income | (0.2) | (0.1) | (0.1) |
| Nonoperating Expenses | 0.3 | 0.0 | -- |
| Income Before Taxes | 31.7 | 19.3 | 7.9 |
| Income Taxes | 12.1 | 7.3 | 2.4 |
| Net Income After Taxes | 19.6 | 12.0 | 5.4 |
| Continuing Operations | 19.6 | 12.0 | 5.4 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 19.6 | 12.0 | 5.4 |
| Total Net Income | 19.6 | 12.0 | 5.4 |
| Net Profit Margin | 7.6% | 7.2% | 5.2% |
| Diluted EPS from Total Net Income | 1.35 | 0.81 | 0.38 |
| Dividends per Share | -- | -- | -- |
All amounts in millions of US Dollars except per share amounts.
Medifast, Inc. Balance Sheet
| Assets | Dec 10 | Dec 09 | Dec 08 |
| Current Assets | |||
| Cash | 17.2 | 12.7 | 1.8 |
| Net Receivables | 0.6 | 0.7 | 0.6 |
| Inventories | 19.5 | 11.2 | 13.9 |
| Other Current Assets | 23.3 | 10.1 | 4.9 |
| Total Current Assets | 60.7 | 34.7 | 21.2 |
| Net Fixed Assets | 30.6 | 23.2 | 21.7 |
| Other Noncurrent Assets | 2.8 | 4.8 | 8.1 |
| Total Assets | 94.1 | 62.8 | 51.0 |
| Liabilities | Dec 10 | Dec 09 | Dec 08 |
| Current Liabilities | |||
| Accounts Payable | -- | 5.0 | 3.7 |
| Short-Term Debt | 0.9 | 0.8 | 3.4 |
| Other Current Liabilities | 15.0 | 0.4 | 1.5 |
| Total Current Liabilities | 16.0 | 6.2 | 8.6 |
| Long-Term Debt | 4.9 | 5.4 | 4.3 |
| Other Noncurrent Liabilities | 1.3 | 1.6 | 0.0 |
| Total Liabilities | 22.1 | 13.2 | 12.9 |
| Shareholder's Equity | |||
| Preferred Stock Equity | 0.0 | 0.0 | -- |
| Common Stock Equity | 72.0 | 49.6 | 38.2 |
| Total Equity | 72.0 | 49.6 | 38.2 |
| Shares Outstanding (thou.) | 15,431.1 | 15,031.1 | 14,332.2 |
All amounts in millions of US Dollars except per share amounts.
Medifast, Inc. Cash Flow Statement
| Dec 10 | Dec 09 | Dec 08 | |
| Net Operating Cash Flow | 29 | 20 | 5 |
| Net Investing Cash Flow | (23.5) | (7.9) | (7.3) |
| Net Financing Cash Flow | 1.3 | (1.5) | 1.5 |
| Net Change in Cash | 6.6 | 10.9 | (0.4) |
| Depreciation & Amortization | 5.9 | 5.3 | 4.6 |
| Capital Expenditures | (12.1) | (5.4) | (7.4) |
| Cash Dividends Paid |
All amounts in millions of US Dollars except per share amounts.


